Infant Phototherapy Device Market Report by Light Source (Fluorescent Lamps, Light Emitting Diodes, Quartz Halogen Lamps, Gas Discharge Tubes), Configuration (Mobile Device, Fixed Device), End User (Hospitals, Neonatal Clinics), Country and Company Analysis 2024-2032

Infant Phototherapy Market Outlook

The Global Infant Phototherapy Device Market size was valued at US$ 96.44 Million in 2023. It is projected to increase at a CAGR of 3.89% from 2024 to 2032. Renub Research forecasted the value to be US$ 135.97 Million by 2032.

Phototherapy devices are used to treat infant jaundice, which is frequently perceived in newborn babies. Phototherapy is the most popular method for lowering the level of bilirubin, a compound that causes jaundice. During phototherapy, the infant is exposed to intense fluorescent light while lying in a plastic cot, and its bare skin absorbs the light. This treatment utilizes a specific wavelength of light that breaks bilirubin into a more straightforward water-soluble form, readily excreted through urine and stool.

Infant Population Worldwide Survey:

• As per the U.S. Census Bureau, the U.S. population is projected to reach nearly 370 million in 2080.
• As stated by CDC, the number of births in 2021 was 3,664,292. Furthermore, the birth rate in the United States was 11.0 per 1,000 people, and the fertility rate was 56.3 births per 1000 women aged 15-44.
• According to the National Population Register (NPR) operated by the Indian government, India has more births annually worldwide. The United Nations estimates around 24 million each year, but the actual figure is probably greater because many births remain unregistered.
• In response to concerns about population growth, China lifted its stringent "one-child policy" in 2016 and began allowing couples to have up to three children in 2021. As stated by NBS (the National Bureau of Statistics, with 9.02 million births in 2023, there were 6.39 births per 1,000 people in China.
• According to INSEE (French National Institute for Statistics and Economic Studies), 678,000 babies were born in France in 2023. The overall fertility rate was 1.68 children per woman.

Disease and Technology Advancements:

•    According to the Children's Liver Disease Foundation, during the first week of birth, jaundice affects 60% of the full-term babies and 80% of the preterm babies. Jaundice peaks at approximately four days of life and then circumspectly disappears in most babies promptly by two weeks old. Hence, the higher usage of phototherapy in newborn babies to treat jaundice will boost the phototherapy device market size.

•    A newborn treated for hyperbilirubinemia in a hospital is usually placed under a stationary halogen light source or illuminator while medical staff monitors the child's condition. Technological developments have produced portable phototherapy units that can be used without the new parents being physically separated. These cutting-edge tools guarantee that the infant can receive treatment for dangerously high bilirubin levels while being fed, held, dressed, diapered, and given other at-home care.

•    For instance, in June 2021, Motif Medical announced the launch of the BilliTouch phototherapy blanket. It is designed to treat babies with jaundice. It’s ultra-portable, battery-powered, and lightweight features make it ideal for use in homes and hospitals.

North America Infant Phototherapy Device Market

North America is a pioneering region that has boosted the infant phototherapy devices market because of its early adoption and advanced healthcare infrastructure. Neonatal jaundice is becoming more common in North America, partly because of a rise in prenatal births and blood type incompatibilities between mothers and fetuses.

As per the Centers for Disease Control and Prevention, about one out of every ten babies born in the United States in 2022 suffered from preterm birth. Hence, the usage of phototherapy devices is driving the market significantly. As healthcare systems advances, more babies receive care, improving jaundice detection and treatment.

Furthermore, the region has set regulations and procedures for treating neonatal jaundice and prioritizes newborn care. North American healthcare providers are well aware of and proficient in phototherapy devices due to their access to the most recent research findings and therapeutic standards.  

Global Infant Phototherapy Devices Company News

Some major companies are present in the global infant phototherapy device industry. These are Ningbo David Medical Device Co., Ltd, Koninklijke Philips N.V., General Electric Company, Inspiration Healthcare Group Plc, Drägerwerk AG & Co. KGaA, Ibis Medical Equipment and Systems Pvt Ltd., Weyer GmbH and Natus Medical Incorporated.

• In November 2023, Drager announced that they are working forward on the development of an intelligent intensive care unit with technology partners and have received funding from the Innovative Health Initiative.
• In September 2022, GenWorks, a Bengaluru-based business, introduced Billicare, a noninvasive (no needles or pins are used to take blood) technology that analyses a baby's bilirubin levels by attaching a clip to their ears.
• In November 2021, NeoLight broadened its portfolio of global newborn care businesses with the acquisition of Phoenix Technology Group, a leader in the ocular screening sector.
• In November 2020, Natus Medical Incorporation announced the acquisition of BabybeGmbh for Innovative Newborn Care Technology. In the neonatal intensive care unit (NICU), Babybe provides technology that allows a mother to interact virtually with her infant.

Light Source – Market breakup in 3 viewpoints:

1.    Fluorescent Lamps
2.    Light Emitting Diodes
3.    Quartz Halogen Lamps
4.    Gas Discharge Tubes

Configuration – Market breakup in 2 viewpoints:

1.    Mobile Device
2.    Fixed Device

End User – Market breakup in 2 viewpoints:

1.    Hospitals
2.    Neonatal Clinics

Country – Market breakup of 25 Countries:

1.    North America

1.1    United States
1.2    Canada

2.    Europe

2.1    France
2.2    Germany
2.3    Italy
2.4    Spain
2.5    United Kingdom
2.6    Belgium
2.7    Netherland
2.8    Turkey

3.    Asia Pacific

3.1    China
3.2    Japan
3.3    India
3.4    South Korea
3.5    Thailand
3.6    Malaysia
3.7    Indonesia
3.8    Australia
3.9    New Zealand

4.    Latin America

4.1    Brazil
4.2    Mexico
4.3    Argentina

5.    Middle East & Africa

5.1    Saudi Arabia
5.2    UAE
5.3    South Africa

All the key players have been covered from 4 Viewpoints:

•    Overview
•    Product Portfolio
•    Recent Development
•    Revenue Analysis

Key Players Analysis:

1.    Ningbo David Medical Device Co.
2.    Ltd, Koninklijke Philips N.V.
3.    General Electric Company
4.    Inapiration Healthcare Group Plc
5.    Drägerwerk AG & Co. KGaA
6.    Ibis Medical Equipment and Systems Pvt Ltd.
7.    Weyer GmbH
8.    Natus Medical Incorporated.

Report Details: